R. Barth, et al., "Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption," Cancer Research, vol. 57, p. 1129, 1997.
 R. F. Barth, et al., "Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine," Int J Radiat Oncol Biol Phys, vol. 52, pp. 858-68, Mar 1 2002.
 C. H. Hsieh, et al., "Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption," J Nucl Med, vol. 46, pp. 1858-65, Nov 2005.
 D. F. Deen, et al., "Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute," J Neurooncol, vol. 16, pp. 243-72, Jun 1993.
 R. J. Motzer, et al., "Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors," J Natl Cancer Inst, vol. 85, pp. 1828-35, Nov 17 1993.
 R. J. Motzer, et al., "High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors," J Clin Oncol, vol. 15, pp. 2546-52, Jul 1997.
 R. K. Puri, et al., "Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein," Int J Cancer, vol. 58, pp. 574-81, Aug 15 1994.
 H. Y. Hong, et al., "Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis," J Cell Mol Med, vol. 12, pp. 2003-14, Oct 2008.